Outcomes Among African American and Non-Hispanic White Men With Metastatic Castration-Resistant Prostate Cancer With First-Line Abiraterone

IMPORTANCE: Prospective evidence suggests abiraterone is associated with superior progression-free survival for African American men compared with non-Hispanic White men with metastatic castration-resistant prostate cancer (mCRPC). OBJECTIVE: To investigate differences in outcomes with first-line ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Marar, Mallika, Long, Qi, Mamtani, Ronac, Narayan, Vivek, Vapiwala, Neha, Parikh, Ravi B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733836/
https://www.ncbi.nlm.nih.gov/pubmed/34985518
http://dx.doi.org/10.1001/jamanetworkopen.2021.42093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733836/
https://www.ncbi.nlm.nih.gov/pubmed/34985518
http://dx.doi.org/10.1001/jamanetworkopen.2021.42093

Ejemplares similares